MiMedx Group entered into a distribution agreement with Zimmer.
Under the agreement, MiMedx will provide its dehydrated human amnion/chorion membrane allograft products to Zimmer to be marketed non-exclusively on a private label basis. Zimmer will market and sell the private-labeled allografts to Zimmer customers and end-users.
"Zimmer has a stellar reputation and is a recognized leader in bringing new technologies and applications to the forefront to serve the reconstructive, sports medicine, trauma, extremities and spinal markets," said Bill Taylor, president and COO of MiMedx. "Our goal is to reach as many patients as possible that will benefit from the regenerative properties of our allografts. Our relationship with Zimmer will allow us to further the realization of that goal."
More articles on devices:
10 key trends in the orthopedic power tools market — Will robotics make it?
Amedica releases Valeo II — 5 quick facts
SpineFrontier brings Tamara Souriolle onboard to boost team education